Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01092910 · ClinicalTrials.gov registry record · NA
Esteem Totally Implantable Hearing System
A NA study of Mild to Severe Sensorineural Hearing Loss, sponsored by Envoy Medical Corporation.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 5
- Study locations
NCT01092910 is a NA study of Mild to Severe Sensorineural Hearing Loss that has completed, run by Envoy Medical Corporation. The registered enrollment target is 57 participants. The trial reports 5 study locations across 3 states.
The verdict
NCT01092910, a NA study of Mild to Severe Sensorineural Hearing Loss, has completed, sponsored by Envoy Medical Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 5
- Study locations
Study Summary
To evaluate the safety and efficacy of the Esteem Totally Implantable Hearing System in subjects suffering from mild to severe hearing loss.
Conditions Studied
Interventions
- DEVICE Esteem Totally Implantable Hearing System
Study Locations (5)
California
- Hoag Memorial Hospital Presbyterian - Newport Beach
- Shohet Ear Associates - Newport Beach
North Carolina
- Surgical Care Affiliates - Greensboro
- The Ear Center of Greensboro - Greensboro
Massachusetts
- Lahey Clinic, Inc. - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01092910
The ClinicalTrials.gov registry entry for NCT01092910 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Envoy Medical Corporation, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mild to Severe Sensorineural Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Esteem Totally Implantable Hearing System is the first listed.
NCT01092910 reports 5 study locations spanning 3 distinct geographic areas - top geographies include California, North Carolina, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01092910 about?
NCT01092910 is a clinical study titled "Esteem Totally Implantable Hearing System". To evaluate the safety and efficacy of the Esteem Totally Implantable Hearing System in subjects suffering from mild to severe hearing loss.
What is the current status of trial NCT01092910?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2008-01. Estimated completion is 2010-08.
What conditions does trial NCT01092910 study?
This clinical trial studies the following conditions: Mild to Severe Sensorineural Hearing Loss.
What interventions are being tested in trial NCT01092910?
The interventions under investigation include: Esteem Totally Implantable Hearing System (DEVICE).
Who is sponsoring clinical trial NCT01092910?
This trial is sponsored by Envoy Medical Corporation, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01092910 being conducted?
This trial has 5 study locations across California, Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.